All In MedTech

FDA Clearance Tracker · P060019-S013

THERAPY COOL PATH ABLATION CATHETER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 3, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 3, 2010

Approved

Time to decision

95 days

Received Aug 30, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P060019-S013
Device name
THERAPY COOL PATH ABLATION CATHETER
Applicant location
Irvine, CA
Received
Aug 30, 2010
Decided
Dec 3, 2010
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P060019

Device type

Device class
Class III

Every decision under product code OAD

FDA's approval statement

As written in FDA's record.

APPROVAL TO CHANGE THE MATERIAL OF THE EXTENSION TUBE TO INCREASE THE TORQUE RESISTANCE OF THE EXTENSION TUBE DURING HANDLE MANIPULATION. THE MATERIAL OF THE EXTENSION TUBE WILL BE CHANGED FROM A NON-BRAIDED PELLETHANE TO A PEBAX BRAIDED TUBE (72D). ADDITIONALLY, THE LENGTH OF THE EXTENSION TUBE AND THE INTERNAL FLUID LUMEN TUBE WILL BE DECREASED FROM 11 CM TO 4 CM.

Source documents

Other decisions for Irvine Biomedical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.